Yingjie Nie

1.1k total citations
41 papers, 714 citations indexed

About

Yingjie Nie is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yingjie Nie has authored 41 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Immunology and 8 papers in Oncology. Recurrent topics in Yingjie Nie's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yingjie Nie is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yingjie Nie collaborates with scholars based in China, United States and Hong Kong. Yingjie Nie's co-authors include De Yang, Joost J. Oppenheim, Chak Sing Lau, Gcf Chan, Albert K. W. Lie, Xin Chen, Anna Trivett, Ying Kuang, Zhiyu Chen and Hidekazu Shirota and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yingjie Nie

40 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingjie Nie China 16 291 260 159 152 90 41 714
Fei Kuang China 13 336 1.2× 328 1.3× 105 0.7× 65 0.4× 43 0.5× 30 822
Francisco Caiado Portugal 17 501 1.7× 298 1.1× 206 1.3× 172 1.1× 148 1.6× 27 1.0k
Kara Scheibner United States 9 464 1.6× 286 1.1× 123 0.8× 125 0.8× 41 0.5× 11 934
Pratibha Singh United States 18 359 1.2× 344 1.3× 162 1.0× 79 0.5× 189 2.1× 47 1.0k
Caroline Duhem Luxembourg 10 165 0.6× 192 0.7× 176 1.1× 137 0.9× 41 0.5× 17 566
Raffi Manoukian United States 12 260 0.9× 327 1.3× 183 1.2× 44 0.3× 73 0.8× 16 726
Olga Zharkova Singapore 11 289 1.0× 246 0.9× 60 0.4× 92 0.6× 27 0.3× 22 567
Catharine J. Andresen United States 17 253 0.9× 210 0.8× 181 1.1× 50 0.3× 39 0.4× 26 833
Min Kyung Kim South Korea 14 293 1.0× 363 1.4× 104 0.7× 74 0.5× 90 1.0× 19 772
Ivana Okić Djordjević Serbia 18 220 0.8× 131 0.5× 110 0.7× 79 0.5× 319 3.5× 38 734

Countries citing papers authored by Yingjie Nie

Since Specialization
Citations

This map shows the geographic impact of Yingjie Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjie Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjie Nie more than expected).

Fields of papers citing papers by Yingjie Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjie Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjie Nie. The network helps show where Yingjie Nie may publish in the future.

Co-authorship network of co-authors of Yingjie Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjie Nie. A scholar is included among the top collaborators of Yingjie Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjie Nie. Yingjie Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Gui, Huan, et al.. (2024). Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer. International Journal of Nanomedicine. Volume 19. 3589–3605. 17 indexed citations
4.
Gui, Huan, et al.. (2024). Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy. International Immunopharmacology. 146. 113918–113918.
6.
Gui, Huan, et al.. (2023). Psychological distress influences lung cancer: Advances and perspectives on the immune system and immunotherapy. International Immunopharmacology. 121. 110251–110251. 15 indexed citations
7.
Chen, Xin, De Yang, Huan Gui, et al.. (2023). Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer. Biochemical and Biophysical Research Communications. 653. 106–114. 9 indexed citations
8.
Zhang, Xiangyan, et al.. (2023). Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model. Frontiers in Pharmacology. 14. 1286061–1286061. 6 indexed citations
9.
Chen, Long, Zhicheng Yao, Siqin Zhang, et al.. (2022). Biomaterial-induced macrophage polarization for bone regeneration. Chinese Chemical Letters. 34(6). 107925–107925. 30 indexed citations
10.
Lv, Xia, Xiangyan Zhang, Qian Zhang, et al.. (2021). lncRNA NEAT1 aggravates sepsis-induced lung injury by regulating the miR-27a/PTEN axis. Laboratory Investigation. 101(10). 1371–1381. 24 indexed citations
11.
Chen, Tao, Fei Wang, Yingjie Nie, et al.. (2021). FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma. Cancer Biology and Medicine. 18(3). 665–674. 9 indexed citations
12.
Li, Hao, Wenguang Zhang, Chong Ren, et al.. (2020). CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway. Cell Biology International. 45(3). 623–632. 22 indexed citations
13.
Cheng, Rong, Wei Li, Klarke M. Sample, et al.. (2020). Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A. PeerJ. 8. e9767–e9767. 4 indexed citations
14.
Cui, Yuxia, Yingjie Nie, Bin Yang, et al.. (2019). Virus isolation and genotype identification of human respiratory syncytial virus in Guizhou Province, China. The Brazilian Journal of Infectious Diseases. 23(6). 427–434. 3 indexed citations
15.
Liu, Lili, Zhiyu Chen, Yingzi Liu, et al.. (2019). Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence. Journal of Cellular and Molecular Medicine. 24(1). 276–284. 33 indexed citations
16.
Nie, Yingjie, Hidekazu Shirota, Anna Trivett, et al.. (2018). Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Science Signaling. 11(511). 58 indexed citations
17.
He, Zhixu, Li Sun, Hui Chen, et al.. (2018). lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346. OncoTargets and Therapy. Volume 11. 8409–8420. 33 indexed citations
18.
Chen, Xin, Yingjie Nie, Haitao Xiao, et al.. (2016). TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis. Scientific Reports. 6(1). 32834–32834. 40 indexed citations
19.
Liu, Shuo, et al.. (2016). Crytotanshinone Induces the Maturation of Human Dendritic Cells through Activation of NF-kB, p38 and JNK MAPKs. The Journal of Immunology. 196(1_Supplement). 142.20–142.20. 2 indexed citations
20.
Jin, Ou, Mo-Yin Mok, Lingyun Sun, et al.. (2010). Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 12(4). R137–R137. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026